Overview

A Study of Various Formulations of LY900014 in Healthy Participants

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
This study will evaluate how quickly the body absorbs, breaks down, and gets rid of the different formulations of LY900014. This study will determine how the different formulations, when injected under the skin, will affect the blood sugar levels in the body, and how safe it is.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin Lispro